MCID: AMY002
MIFTS: 37

Amyloid Tumor malady

Categories: Cancer diseases

Aliases & Classifications for Amyloid Tumor

Aliases & Descriptions for Amyloid Tumor:

Name: Amyloid Tumor 12 14 69
Amyloid Neoplasm 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6755
SNOMED-CT 64 37279009
UMLS 69 C0333572

Summaries for Amyloid Tumor

MalaCards based summary : Amyloid Tumor, also known as amyloid neoplasm, is related to choriodal dystrophy, central areolar 2 and bacteriuria. An important gene associated with Amyloid Tumor is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Neuroscience and FOXA2 and FOXA3 transcription factor networks. The drugs Verapamil and Trandolapril have been mentioned in the context of this disorder. Affiliated tissues include breast, lung and trachea, and related phenotype is neoplasm.

Related Diseases for Amyloid Tumor

Diseases related to Amyloid Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 84)
id Related Disease Score Top Affiliating Genes
1 choriodal dystrophy, central areolar 2 10.3 B2M TTR
2 bacteriuria 10.3 B2M TTR
3 encephalitis 10.3 B2M MYOM2
4 hereditary lymphedema type ii 10.3 B2M TTR
5 acute allergic sanguinous otitis media 10.3 B2M MYOM2
6 denture stomatitis 10.3 B2M TTR
7 tibial nerve palsy 10.3 B2M TTR
8 46 xy gonadal dysgenesis 10.2 B2M CD79A
9 anaplastic ganglioglioma 10.2 B2M TTR
10 pancreatic vasoactive intestinal peptide producing tumor 10.2 B2M TTR
11 congenital nystagmus 10.2 B2M CD79A
12 acute female pelvic peritonitis 10.2 CD79A TTR
13 verrucous carcinoma 10.2 B2M MYOM2
14 hypotrichosis 6 10.2 B2M TTR
15 male genital organ stricture 10.2 CD79A TTR
16 cellulitis 10.2 CD79A TTR
17 angiokeratoma 10.2 B2M CD79A
18 urethral calculus 10.2 CD79A MYOM2
19 watson syndrome 10.2 NF1 NF2
20 generalized atherosclerosis 10.2 CD79A MYOM2
21 ulnar neuropathy 10.2 CD79A NF2
22 lateral medullary syndrome 10.2 NF1 NF2
23 pleural cancer 10.2 NF1 NF2
24 anorectal stricture 10.2 NF1 NF2
25 jejunal somatostatinoma 10.2 NF1 NF2
26 monckeberg arteriosclerosis 10.2 NF1 NF2
27 epilepsy, familial focal, with variable foci 10.2 NF1 NF2
28 hemorrhoid 10.1 B2M PKDREJ
29 dextrocardia 10.1 CD79A MYOM2
30 alopecia areata 10.1 NF1 TUBB3
31 arteriosclerosis 10.1 CD79A MYOM2
32 white piedra 10.1 CD79A TTR TUBB3
33 right bundle branch block 10.1 CD79A TG
34 atheroembolism of kidney 10.1 CD79A TG
35 oliver syndrome 10.1 NF1 TUBB3
36 venezuelan equine encephalitis 10.1 B2M CD79A MYOM2
37 childhood pleomorphic rhabdomyosarcoma 10.1 B2M CD79A MYOM2
38 glycogen storage disease viii 10.1 B2M CD79A
39 ethmoid sinus schneiderian papilloma 10.1 B2M CD79A MYOM2
40 tall cell variant papillary carcinoma 10.1 B2M CD79A MYOM2
41 bubonic plague 10.1 B2M CALCA
42 lingual-facial-buccal dyskinesia 10.1 TG TTR TUBB3
43 malignant hyperthermia susceptibility 1 10.0 B2M CD79A
44 acute cor pulmonale 10.0 CALCA MYOM2
45 ovarian insufficiency due to fsh resistance 10.0 NF1 SPARC
46 glomangiosarcoma 10.0 CD79A MYOM2 NF1
47 atrial heart septal defect 10.0 CALCA NF1
48 brain ependymoma 10.0 CALCA NF1
49 cutis laxa, autosomal recessive, type ib 10.0 B2M CD79A MYOM2
50 t-cell large granular lymphocyte leukemia 10.0 NF1 NF2 PKDREJ

Graphical network of the top 20 diseases related to Amyloid Tumor:



Diseases related to Amyloid Tumor

Symptoms & Phenotypes for Amyloid Tumor

MGI Mouse Phenotypes related to Amyloid Tumor:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.02 B2M CD79A NF1 NF2 SPARC

Drugs & Therapeutics for Amyloid Tumor

Drugs for Amyloid Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 310)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Verapamil Approved Phase 4 52-53-9 2520
2
Trandolapril Approved Phase 4 87679-37-6 5484727
3
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
4
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
5
Atenolol Approved Phase 4 29122-68-7 2249
6
protease inhibitors Phase 4,Phase 3,Phase 2,Phase 1
7 Adrenergic Agents Phase 4,Phase 2,Phase 3,Phase 1
8 Adrenergic Antagonists Phase 4,Phase 2,Phase 3,Phase 1
9 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Adrenergic beta-Antagonists Phase 4,Phase 2,Phase 3,Phase 1
11 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
12 Hormones Phase 4,Phase 3,Phase 2,Phase 1
13 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
14 Vasodilator Agents Phase 4,Phase 2,Phase 3,Phase 1
15 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3,Phase 1
16 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
17 Antihypertensive Agents Phase 4,Phase 2,Phase 3,Phase 1
18 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
19
Angiotensin II Phase 4 68521-88-0, 11128-99-7 65143 172198
20 calcium channel blockers Phase 4
21 diuretics Phase 4
22 Natriuretic Agents Phase 4
23 Sodium Chloride Symporter Inhibitors Phase 4
24 Adrenergic beta-1 Receptor Antagonists Phase 4
25 Sympatholytics Phase 4
26 Angiotensin II Type 1 Receptor Blockers Phase 4
27 Angiotensin Receptor Antagonists Phase 4
28 Angiotensin-Converting Enzyme Inhibitors Phase 4
29 Angiotensinogen Phase 4
30 Calcium, Dietary Phase 4,Phase 1,Phase 2
31
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
32
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
33
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
34
Flutamide Approved Phase 3,Phase 2 13311-84-7 3397
35
Propranolol Approved, Investigational Phase 2, Phase 3,Phase 1 525-66-6 4946
36
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
37
Leuprolide Approved, Investigational Phase 3,Phase 2 53714-56-0 3911 657181
38
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
39
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
40
Lenalidomide Approved Phase 3,Phase 2,Phase 1 191732-72-6 216326
41
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
42
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
43
Morphine Approved, Investigational Phase 3 57-27-2 5288826
44
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
45
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
46
Ondansetron Approved Phase 3 99614-02-5 4595
47
Mechlorethamine Approved Phase 3,Phase 1,Phase 2 51-75-2 4033
48
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
49
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
50
Dalteparin Approved Phase 3 9041-08-1

Interventional clinical trials:

(show top 50) (show all 188)
id Name Status NCT ID Phase
1 Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus Completed NCT00982358 Phase 4
2 INVEST: INternational VErapamil SR Trandolapril STudy Completed NCT00133692 Phase 4
3 TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer Recruiting NCT02290782 Phase 4
4 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3
5 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Completed NCT00477971 Phase 3
6 Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis Completed NCT01078454 Phase 3
7 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3
8 Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00004165 Phase 3
9 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
10 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
11 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3
12 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
13 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
14 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3
15 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3
16 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
17 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
18 Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis Completed NCT00035334 Phase 2, Phase 3
19 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
20 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3
21 Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis Recruiting NCT01659658 Phase 3
22 Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy Recruiting NCT02791230 Phase 3
23 Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Active, not recruiting NCT00567580 Phase 3
24 The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis Active, not recruiting NCT02312206 Phase 3
25 Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients Suspended NCT00211952 Phase 3
26 Trial of HDM/SCT Versus HDM + Bortezomib/SCT in AL Amyloidosis Suspended NCT02489500 Phase 3
27 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease Terminated NCT01012414 Phase 3
28 Propranolol in Capillary Hemangiomas Terminated NCT00744185 Phase 2, Phase 3
29 Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients Terminated NCT00676143 Phase 3
30 Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Terminated NCT00667810 Phase 3
31 S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis Unknown status NCT00064337 Phase 2
32 CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis Unknown status NCT00558896 Phase 2
33 Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy Unknown status NCT00223665 Phase 2
34 Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors Unknown status NCT00003515 Phase 2
35 Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) Unknown status NCT00981708 Phase 1, Phase 2
36 Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers Unknown status NCT00003163 Phase 2
37 Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis Completed NCT00089167 Phase 2
38 Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis Completed NCT00458822 Phase 2
39 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis Completed NCT00007995 Phase 2
40 High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis Completed NCT00003353 Phase 2
41 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis Completed NCT00003853 Phase 2
42 High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis Completed NCT00002810 Phase 2
43 Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction Completed NCT00547365 Phase 1, Phase 2
44 Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis Completed NCT00017680 Phase 2
45 Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Completed NCT00564889 Phase 2
46 S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis Completed NCT00002849 Phase 2
47 Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden Completed NCT00651937 Phase 2
48 Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients Completed NCT00129376 Phase 2
49 Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer Completed NCT00464646 Phase 2
50 Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis Completed NCT00166413 Phase 2

Search NIH Clinical Center for Amyloid Tumor

Genetic Tests for Amyloid Tumor

Anatomical Context for Amyloid Tumor

MalaCards organs/tissues related to Amyloid Tumor:

39
Breast, Lung, Trachea, Thyroid, Tongue, Skin, B Cells

Publications for Amyloid Tumor

Articles related to Amyloid Tumor:

(show top 50) (show all 69)
id Title Authors Year
1
Incidental Discovery of Multiple Myeloma, Presenting as an Amyloid Tumor with Plasmacytic Elements of the Thoracic Wall. ( 26710503 )
2015
2
Calcified amyloid tumor of neck with exuberant giant cell reaction. ( 25949063 )
2015
3
Prostate amyloid tumor is a clue leading to the diagnosis of systemic AL amyloidosis. ( 23826754 )
2013
4
Amyloid tumor behaving as localized amyloidosis in a patient with long history of asymptomatic light chain myeloma. ( 23882901 )
2013
5
Amyloid tumor of the stomach simulating an obstructing gastric carcinoma: case report and review of the literature. ( 19288419 )
2009
6
Solitary amyloid tumor of the tongue base. ( 20107570 )
2009
7
Amyloid tumor of the breast mimicking breast carcinoma. ( 18364625 )
2008
8
Intracranial Aspergillus infection associated with an amyloid tumor and lymphoma. ( 19412411 )
2008
9
Fine needle aspiration cytology of a primary amyloid tumor of the breast. ( 15085770 )
2004
10
Amyloid tumor of the larynx associated with plasma cell infiltration: differential diagnosis. ( 15724743 )
2004
11
Aspiration cytology diagnosis of a primary amyloid tumor of thoracic vertebra: a case report. ( 15282731 )
2004
12
Amyloid tumor in the anterior mediastinum: report of a case. ( 15170548 )
2004
13
Isolated amyloid tumor in the mediastinum: report of a case. ( 12658387 )
2003
14
Aspiration cytology diagnosis of a primary amyloid tumor of thoracic vertebra: a case report. ( 12951685 )
2003
15
Amyloid tumor: a clinical and cytomorphologic study. ( 12768639 )
2003
16
AA-type amyloid tumor as an unsuspected cause of residual mass in a patient with large B-cell non-Hodgkin's lymphoma. ( 12002783 )
2002
17
Aspiration biopsy findings in amyloid tumor of the cervical vertebra. A case report. ( 11393073 )
2001
18
Localized amyloid tumor of the nasopharynx. ( 10652414 )
2000
19
Localized amyloid tumor in small bowel. ( 11052330 )
2000
20
Primary amyloid tumor (amyloidoma) of the jejunum with spheroid type of amyloid. ( 10212914 )
1999
21
Intraabdominal immunoglobulin light chain amyloid tumor encompassing a vascular malformation. ( 9625589 )
1998
22
Primary amyloidoma (amyloid tumor) of soft tissue. ( 9622729 )
1998
23
Localized amyloid tumor of the tongue. A case report and review of the literature. ( 15678860 )
1998
24
Primary localized amyloid tumor of the breast with osseous metaplasia. ( 9701018 )
1998
25
Primary amyloid tumor of the breast: a case report and review of the literature. ( 9237186 )
1997
26
Clinical and computed tomographic characteristics of amyloid tumor of the lacrimal gland. ( 8764792 )
1996
27
Recurrent amyloid tumor of the parotid gland. ( 7536425 )
1995
28
Amyloid tumor of the sacrum. A case report. ( 7762341 )
1995
29
Ga-67 and Tc-99m (V) DMSA imaging in non-Hodgkin's lymphoma with amyloid tumor. ( 8565385 )
1995
30
Localized primary amyloid tumor associated with osseous metaplasia presenting as bilateral breast masses: cytologic and radiologic features. ( 8287770 )
1993
31
Localized primary amyloid tumor of the thyroid developing in the course of Hashimoto's thyroiditis. ( 1570743 )
1992
32
[Craniocervical amyloid tumor with destructive spondyloarthropathy and myelocompression as a rare complication of long-term dialysis]. ( 2108522 )
1990
33
Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient. ( 2674745 )
1989
34
Localized primary amyloid tumor of the parotid gland. ( 3186222 )
1988
35
Case report 480: Periosteal amyloid tumor. ( 3375853 )
1988
36
Amyloid tumor of the spleen. ( 3307463 )
1987
37
Localized primary (AL) amyloid tumor of the breast. Cytologic, histologic, immunocytochemical and ultrastructural observations. ( 3526931 )
1986
38
Amyloid tumor (amyloidoma) of a peripheral nerve. ( 3021087 )
1986
39
Primary amyloid tumor of the breast. Case report and literature review. ( 3855589 )
1985
40
Case report 233. Amyloid tumor of the sternum as part of a solitary plasmacytoma. ( 6879219 )
1983
41
Amyloid tumor of the breast. ( 6831938 )
1983
42
Primary amyloid tumor of the lacrimal gland: CT findings. ( 6630639 )
1983
43
Amyloid tumor of the breast. ( 7166121 )
1982
44
Amyloid tumor of the orbit. ( 492520 )
1979
45
A case of amyloid tumor of the stomach. ( 631096 )
1978
46
Amyloid tumor. A clinicopathologic study of four cases. ( 148847 )
1978
47
Case report. Localized amyloid tumor of the bladder presenting as an anterior pelvic mass. ( 1155740 )
1975
48
Amyloid tumor of the breast. ( 4683157 )
1973
49
Amyloid tumor of the larynx. Case report with electron microscope study. ( 5030768 )
1972
50
Primary amyloid tumor of the trachea. A case report. ( 5022950 )
1972

Variations for Amyloid Tumor

Expression for Amyloid Tumor

Search GEO for disease gene expression data for Amyloid Tumor.

Pathways for Amyloid Tumor

Pathways related to Amyloid Tumor according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.43 CALCA NF1 NF2 TUBB3
2 10.6 NF1 TTR

GO Terms for Amyloid Tumor

Biological processes related to Amyloid Tumor according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 regulation of cell proliferation GO:0042127 9.63 NF1 NF2 SPARC
2 cellular protein metabolic process GO:0044267 9.61 B2M CALCA TTR
3 extracellular matrix organization GO:0030198 9.58 NF1 SPARC TTR
4 pigmentation GO:0043473 9.48 NF1 SPARC
5 negative regulation of endothelial cell proliferation GO:0001937 9.37 NF1 SPARC
6 response to cadmium ion GO:0046686 9.32 B2M SPARC
7 negative regulation of osteoclast differentiation GO:0045671 9.26 CALCA NF1
8 negative regulation of MAPK cascade GO:0043409 9.16 NF1 NF2
9 negative regulation of cell-matrix adhesion GO:0001953 8.96 NF1 NF2
10 positive regulation of adenylate cyclase activity GO:0045762 8.62 CALCA NF1

Molecular functions related to Amyloid Tumor according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.8 CALCA TG TTR

Sources for Amyloid Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....